Epstein, Alan L. Litigation, Intellectual Property, Attorneys, SEC Filings, and Other Public Records

Federal Dockets	16
State Dockets	1
Active	1985–2002
Patent Assignments	37

On PlainSite Chat

No one has posted about Epstein, Alan L. yet.

Share something about Epstein, Alan L.:

Add a document

Date Recorded	Party	Role	Document Type	Document No.	Invention Title

1/23/2025	University Of Southern California	Assignee	Application Publication	18669185 20250129171	Car T-cell Therapy Directed To Lhr For The Treatment Of Solid Tumors Car T-cell Therapy Directed To Lhr For The Treatment Of Solid Tumors

1/23/2025	University Of Southern California	Assignee	Application Publication	18669185 20250129171	Car T-cell Therapy Directed To Lhr For The Treatment Of Solid Tumors Car T-cell Therapy Directed To Lhr For The Treatment Of Solid Tumors

8/27/2024	University Of Southern California	Assignee	Application Publication	18141116 20240150470	Lym-1 And Lym-2 Antibody Compositions And Improved Car Constructs Lym-1 And Lym-2 Antibody Compositions And Improved Car Constructs

8/27/2024	University Of Southern California	Assignee	Application Publication	18141116 20240150470	Lym-1 And Lym-2 Antibody Compositions And Improved Car Constructs Lym-1 And Lym-2 Antibody Compositions And Improved Car Constructs

8/9/2024	University Of Southern California	Assignee	Application Publication	18620185 20240392011	Hla-g As A Novel Target For Car T-cell Immunotherapy Hla-g As A Novel Target For Car T-cell Immunotherapy

8/9/2024	University Of Southern California	Assignee	Application Publication	18620185 20240392011	Hla-g As A Novel Target For Car T-cell Immunotherapy Hla-g As A Novel Target For Car T-cell Immunotherapy

8/9/2024	University Of Southern California	Assignee	Application Publication	18620185 20240392011	Hla-g As A Novel Target For Car T-cell Immunotherapy Hla-g As A Novel Target For Car T-cell Immunotherapy

8/13/2021	University Of Southern California	Assignee	Application Publication	17402300 20220056139	Lym-1 And Lym-2 Antibody Compositions And Improved Car Constructs Lym-1 And Lym-2 Antibody Compositions And Improved Car Constructs

7/8/2021	University Of Southern California	Assignee	Application Publication Patent	15561967 20180112003 11136401	Car T-cell Therapy Directed To Lhr For The Treatment Of Solid Tumors Car T-cell Therapy Directed To Lhr For The Treatment Of Solid Tumors Car T-cell Therapy Directed To Lhr For The Treatment Of Solid Tumors

2/9/2021	University Of Southern California	Assignee	Application Publication	14420308 20150218280	CD20 scFv-ELPs METHODS AND THERAPEUTICS CD20 scFv-ELPs METHODS AND THERAPEUTICS

2/9/2021	University Of Southern California	Assignee	Application Application Publication Publication	16254531 14420308 20150218280 20200079868	CD20 scFv-ELPs METHODS AND THERAPEUTICS CD20 scFv-ELPs METHODS AND THERAPEUTICS CD20 scFv-ELPs METHODS AND THERAPEUTICS CD20 scFv-ELPs METHODS AND THERAPEUTICS

2/9/2021	University Of Southern California	Assignee	Application Application Publication Publication Patent	14420308 16254531 20150218280 20200079868 10961317	CD20 scFv-ELPs METHODS AND THERAPEUTICS CD20 scFv-ELPs METHODS AND THERAPEUTICS CD20 scFv-ELPs METHODS AND THERAPEUTICS CD20 scFv-ELPs METHODS AND THERAPEUTICS CD20 scFv-ELPs METHODS AND THERAPEUTICS

10/16/2020	University Of Southern California	Assignee	Application Publication	16923387 20210147551	Lym-1 And Lym-2 Targeted Car Cell Immunotherapy Lym-1 And Lym-2 Targeted Car Cell Immunotherapy

3/22/2019	University Of Southern California	Assignee	Application Publication	16335570 20200016201	Chimeric Antigen Receptors And Compositions And Methods Of Use Thereof Chimeric Antigen Receptors And Compositions And Methods Of Use Thereof

12/5/2017	University Of Southern California	Assignee	Application Publication	15570747 20180291089	Secretory Tnt Car Cell Immunotherapy Secretory Tnt Car Cell Immunotherapy

11/2/2017	University Of Southern California	Assignee	Application Publication	15561966 20190119385	Hla-g As A Novel Target For Car T-cell Immunotherapy Hla-g As A Novel Target For Car T-cell Immunotherapy

8/10/2016	University Of Southern California	Assignee	Application Publication	15173534 20160355590	Lym-1 And Lym-2 Targeted Car Cell Immunotherapy Lym-1 And Lym-2 Targeted Car Cell Immunotherapy

8/10/2016	University Of Southern California	Assignee	Application Publication Patent	15173534 20160355590 10221241	Lym-1 And Lym-2 Targeted Car Cell Immunotherapy Lym-1 And Lym-2 Targeted Car Cell Immunotherapy Lym-1 And Lym-2 Targeted Car Cell Immunotherapy

8/10/2016	University Of Southern California	Assignee	Application Publication Patent	15173534 20160355590 10711064	Lym-1 And Lym-2 Targeted Car Cell Immunotherapy Lym-1 And Lym-2 Targeted Car Cell Immunotherapy Lym-1 And Lym-2 Targeted Car Cell Immunotherapy

5/7/2012	University Of Southern California	Assignee	Application Publication Patent	13458788 20120276004 8883497	Human Myeloid Derived Suppressor Cell Cancer Markers Human Myeloid Derived Suppressor Cell Cancer Markers Human Myeloid Derived Suppressor Cell Cancer Markers

7/6/2009	University Of Southern California	Assignee	Application Publication Patent	12419960 20090274653 7803361	Therapeutic Use Of Interleukin-2 Mutants Therapeutic Use Of Interleukin-2 Mutants Therapeutic Use Of Interleukin-2 Mutants

1/7/2009	University Of Southern California	Assignee	Application Publication Patent	11093073 20060292116 7514073	Therapeutic Use Of Interleukin-2 Mutants Therapeutic Use Of Interleukin-2 Mutants Therapeutic Use Of Interleukin-2 Mutants

12/27/2007	The University Of Southern California	Assignee	Application Publication Patent	10142120 20020164302 6737064	Vasopermeability Enhancing Peptide Of Human Interleukin-2 And Immunoconj... Vasopermeability Enhancing Peptide Of Human Interleukin-2 And Immunoconj... Vasopermeability Enhancing Peptide Of Human Interleukin-2 And Immunoconj...

2/23/2006	University Of Southern California	Assignee	Application Publication	11269123 20060135459	Cancer Targeted Innate Immunity Cancer Targeted Innate Immunity

6/14/2005	University Of Southern California	Assignee	Application Publication	11045507 20050214286	Polymer-bound antibody cancer therapeutic agent Polymer-bound antibody cancer therapeutic agent

7/12/2004	University Of Southern California	Assignee	Application Publication Patent	10779267 20040228836 8795672	Compositions and methods for cancer immunotherapy Compositions and methods for cancer immunotherapy Compositions and methods for cancer immunotherapy

3/30/2004	University Of Southern California	Assignee	Application Publication Patent	10218197 20030124678 7371371	Interleukin-2 Mutants With Reduced Toxicity Interleukin-2 Mutants With Reduced Toxicity Interleukin-2 Mutants With Reduced Toxicity

3/26/2004	University Of Southern California	Assignee	Application Publication Patent	10218197 20030124678 7371371	Interleukin-2 Mutants With Reduced Toxicity Interleukin-2 Mutants With Reduced Toxicity Interleukin-2 Mutants With Reduced Toxicity

10/29/2001	University Of Southern California	Assignee	Application Publication Patent	09916883 20020068328 6524823	Vasopermeability-enhancing Conjugates Vasopermeability-enhancing Conjugates Vasopermeability-enhancing Conjugates

1/8/2001	Southern California, University Of	Assignee	Application Patent	09382359 6274343	Vasopermeability Enhancing Immunoconjugates Vasopermeability Enhancing Immunoconjugates

11/18/1999	University Of Southern California	Assignee	Application Patent	09443061 6403096	Vasopermeability Enhancing Peptide Of Human Interleukin-2 And Immunoconj... Vasopermeability Enhancing Peptide Of Human Interleukin-2 And Immunoconj...

5/19/1997	Techniclone International	Assignee	Application Patent	08781449 5990286	Antibodies With Reduced Net Positive Charge Antibodies With Reduced Net Positive Charge

12/23/1996	Southern California, University Of	Assignee	Application Patent	08806121 6008319	Vasopermeability Enhancing Peptide Of Human Interleukin-2 And Immunoconj... Vasopermeability Enhancing Peptide Of Human Interleukin-2 And Immunoconj...

10/5/1990	Techniclone, Inc.	Assignee	Application Patent	07579375 5194594	Modified Antibodies Modified Antibodies

12/5/1986	Cancer Biologics, Inc.	Assignee	Application Application Patent Patent	06938425 06938425 4861581 4861581	Detection Of Necrotic Malignant Tissue And Associated Therapy Detection Of Necrotic Malignant Tissue And Associated Therapy Detection Of Necrotic Malignant Tissue And Associated Therapy Detection Of Necrotic Malignant Tissue And Associated Therapy

6/17/1985	Northwestern University	Assignee	Application Patent	06738083 4724212	Murine Hybridoma Lym-2 And Diagnostic Antibody Produced Thereby Murine Hybridoma Lym-2 And Diagnostic Antibody Produced Thereby

6/17/1985	Northwestern University	Assignee	Application Patent	06738084 4724213	Murine Hybridoma Lym-1 And Diagnostic Antibody Produced Thereby Murine Hybridoma Lym-1 And Diagnostic Antibody Produced Thereby

37 Rows Total

Incoming Payments

This individual has not disclosed any incoming payments from lobbying groups.

Outgoing Payments

This individual has not disclosed any outgoing payments to lobbying groups.

AI text generation	None
AI document summarization	None
AI-augmented search	None
AI-generated images	None
AI chat or Q&A interface	Linkable via MCP
Third party AI contribution in government documents	Possible